ACE2 Elevation in Severe COVID-19 is a research paper published in American Journal of Respiratory and Critical Care Medicine (2021). On theSindex it has a DataRank of 0.710. It has been cited 113 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.710
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Austrian Science Fund (FWF)
Grant: KLI 861
COVID-19 and RAS Inhibition
Canadian Institutes of Health Research
Grant: unidentified
unidentified
Fields of Study
Keywords
Additional file 1 of High D-glucose levels induce ACE2 expression via GLUT1 in human airway epithelial cell line Calu-3
Additional file 1 of High D-glucose levels induce ACE2 expression via GLUT1 in human airway epithelial cell line Calu-3